首页> 外文期刊>Journal of Thoracic Disease >Staged percutaneous coronary intervention followed by minimally invasive mitral valve surgery versus combined coronary artery bypass graft and mitral valve surgery for two-vessel coronary artery disease and moderate to severe ischemic mitral regurgitation
【24h】

Staged percutaneous coronary intervention followed by minimally invasive mitral valve surgery versus combined coronary artery bypass graft and mitral valve surgery for two-vessel coronary artery disease and moderate to severe ischemic mitral regurgitation

机译:分期经皮冠状动脉介入治疗,然后微创二尖瓣手术与联合冠状动脉搭桥术和二尖瓣手术相结合,可治疗两支冠状动脉疾病和中度至重度缺血性二尖瓣反流

获取原文
           

摘要

Background: The optimal treatment for concomitant two-vessel coronary artery disease (CAD) and moderate to severe ischemic mitral regurgitation (IMR) remains unclear. We compared the results of a staged percutaneous coronary intervention followed by minimally invasive mitral valve surgery (PCI+MIVS) versus combined coronary artery bypass graft and mitral valve surgery (CABG+MVS) in this population. Methods: All consecutive patients with two-vessel CAD and moderate to severe IMR, who underwent PCI+MIVS or CABG+MVS at our institution between February 2009 and April 2014, were retrospectively evaluated. Results: There were nine patients identified who underwent PCI+MIVS, and 15 who underwent CABG+MVS, with a mean age of 71±7, and 70±7 years, respectively (P=0.86). The remaining baseline characteristics were similar between both groups, with the exception of a higher prevalence of pre-operative clopidogrel administration (78% versus 27%, P=0.03) and left anterior descending plus left circumflex CAD (78% versus 27%, P=0.03), in those who underwent PCI+MIVS. The PCI+MIVS approach was associated with decreased mean cardiopulmonary bypass (111±41 versus 167±49 min, P=0.01) and aortic cross-clamp (79±32 versus 129±35 min, P=0.003) times, and less median number of intraoperative packed red blood transfusions {2 [interquartile range (IQR), 0–2] versus 3 units (IQR, 1–4), P=0.05}, when compared with CABG+MVS. The rate of mitral valve repair, postoperative complications, 30-day mortality, and 1-year survival did not differ between the surgical approaches. Conclusions: PCI+MIVS for two-vessel CAD and moderate to severe IMR is feasible, and associated with satisfactory outcomes, as compared with CABG+MVS.
机译:背景:对于伴发两支冠状动脉疾病(CAD)和中重度缺血性二尖瓣关闭不全(IMR)的最佳治疗方法尚不清楚。我们比较了该人群中分期经皮冠状动脉介入治疗后微创二尖瓣手术(PCI + MIVS)与冠状动脉搭桥术和二尖瓣手术联合(CABG + MVS)的结果。方法:回顾性分析2009年2月至2014年4月在我院接受PCI + MIVS或CABG + MVS治疗的所有两支血管CAD和中重度IMR患者。结果:确定的9例行PCI + MIVS的患者和15例行CABG + MVS的患者,平均年龄分别为71±7岁和70±7岁(P = 0.86)。除术前使用氯吡格雷的患病率较高(78%vs 27%,P = 0.03)和左前降支加左旋支CAD(78%vs 27%,P)外,其余两组的基线特征相似。 = 0.03),接受PCI + MIVS的患者。 PCI + MIVS方法与平均心肺旁路减少(111±41 vs 167±49 min,P = 0.01)和主动脉夹钳(79±32 vs 129±35 min,P = 0.003)次数相关,且中位数较少与CABG + MVS相比,术中密集输血的次数{2 [四分位间距(IQR),0-2]相对于3个单位(IQR,1-4),P = 0.05}。二尖瓣修复率,术后并发症,30天死亡率和1年生存率在两种手术方法之间没有差异。结论:与CABG + MVS相比,PCI + MIVS用于两支血管CAD和中至重度IMR是可行的,并且具有令人满意的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号